BioCryst Pharmaceuticals Inc (BCRX)
ETFs that hold BioCryst Pharmaceuticals Inc (BCRX)
BioCryst Pharmaceuticals Inc is held by 9 ETFs tracked in our database. The largest position is held by XBI (0.56%), a sector fund. The remaining funds hold it at 0.13% or less. The largest holders are all small-cap and sector funds.
ETFs holding BioCryst Pharmaceuticals Inc (BCRX) in our database, ranked by portfolio weight.
Which ETFs hold BioCryst Pharmaceuticals Inc (BCRX)?
The ETFs with the largest positions in BioCryst Pharmaceuticals Inc (BCRX) are: SPDR S&P Biotech ETF (XBI, 0.56%); iShares Russell 2000 Growth ETF (IWO, 0.13%); iShares Biotechnology ETF (IBB, 0.12%); iShares Russell 2000 ETF (IWM, 0.12%); Vanguard Small-Cap Growth ETF (VBK, 0.03%). The full list, ranked by weight, is in the table.
How many ETFs hold BioCryst Pharmaceuticals Inc (BCRX)?
BioCryst Pharmaceuticals Inc (BCRX) is held by 9 ETFs tracked in our database. The largest position is in XBI, where it makes up 0.56% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. XBI holds BioCryst Pharmaceuticals Inc (BCRX) at 0.56%, and the simple average weight across the 9 funds is 0.11%.